Please wait
N/A0001674416N/AEX-FILING FEESS-3424B5000167441612025-10-152025-10-1500016744162025-10-152025-10-15xbrli:pureiso4217:USD

Exhibit 107

Calculation of Filing Fee Table

424(b)(5)

(Form Type)

CRISPR Therapeutics AG

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Security

Type

Security

Class Title

Fee
Calculation

or Carry
Forward
Rule

Amount
Registered

Proposed
Maximum
Offering
Price Per

Unit

Maximum
Aggregate
Offering
Price(1)

Fee Rate

Amount of
Registration
Fee(1)

Newly Registered Securities

Fees to Be Paid

Equity

Common Shares,

CHF 0.03 nominal value

457(o) and 457(r)

$600,000,000.00

0.0001381

$82,860.00

Fees Previously Paid

 

 

 

 

 

 

 

 

 

Carry Forward Securities

Carry Forward Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Offering Amounts

 

 

 

$600,000,000.00

 

 

 

$82,860.00

 

 

Total Fees Previously Paid

 

 

 

 

 

 

 

 

 

Total Fee Offsets

 

 

 

 

 

 

 

 

Net Fee Due

 

 

$82,860.00

(1)

Calculated in accordance with Rule 457(o) and Rule 457(r) under the Securities Act of 1933, as amended (the “Securities Act”). This registration fee table shall be deemed to update the “Calculation of Registration Fee” table in the registrant’s Registration Statement on Form S-3ASR (File No. 333-281262), which was filed on August 5, 2024, in accordance with Rules 456(b) and 457(r) under the Securities Act.